Stephan Strass

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 5
            [name] => Attorney at Law
            [slug] => attorney-at-law
            [term_group] => 0
            [term_taxonomy_id] => 5
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 15
            [filter] => raw
        )

    [1] => WP_Term Object
        (
            [term_id] => 4
            [name] => Partner
            [slug] => partner
            [term_group] => 0
            [term_taxonomy_id] => 4
            [taxonomy] => category
            [description] => Partner
            [parent] => 0
            [count] => 8
            [filter] => raw
        )

)

Partner

Practice area

Get in touch

Personal Assistant

Michelle Wavrouschek

About Stephan Strass

Stephan advises innovative start-ups, institutional and strategic investors and other companies on acquisitions, financing rounds, joint ventures and exit transactions with a focus on highly regulated industries such as life sciences, biotech and leisure & entertainment. He further specializes in commercial transactions in the life science and biotech sector, including university spin-offs, strategic collaborations, patent and technology license agreements and IP purchase transactions.

He has co-authored commentaries on the EU Merger Act and the Investment Fund Act, and is the author of many academic publications.

University of Vienna, Faculty of Law (Mag. iur. 2015)

Harvard Law School, Master of Laws (LL.M. 2019)

» Stephan Strass already has an outstanding market reputation and leads a broad range of M&A projects for a variety of clients mainly from the tech sector. Stephan is very hands-on, extremely experienced and always available. He has a dedicated focus on the life sciences and biotech sector and advises many clients also on commercial transactions. Stephan is, without any doubt, one of the few rising stars in the Austrian M&A market. «

Legal 500

Working highlights

Advising the shareholders of Allcyte on the sale to Exscientia

Advising the seller consortium, including Farallon, Global Health Investment Fund, Wellington Partners and Ventech on the sale of Themis to Merck Sharp Dohme

Advising numerous start-ups and other companies in the life sciences sector on university spin-offs and technology transactions

Advising Sportradar on its initial public offering on NASDAQ

Advising AC Immune on the acquisition of a vaccine candidate against Parkinson's disease (Affiris)

Publications

Investitionskontrolle 2.0 – neue Hürde für Venture Capital- Investments?, Ecolex p. 862 | 2020 Absicherung des Investors bei Finanzierungsrunden - Sachgerechte Gewährleistungs- und Haftungsmodelle im Überblick, CFO aktuell p. 139-141 | 2017 Kapitalaufbringung und -erhaltung bei der Abgabe von Gewährleistungen duch die Gesellschaft iZm Kaptialerhöhungen, wbl p. 730-741 | 2016

Latest insights by
Stephan Strass

BRANDL TALOS advises Pride Capital Partners on the acquisition of a minority stake in RUBICON alongside RSM Ebner Stolz

Press release • Venture Capital & Start Ups from Roman Rericha, Stephan Strass, Adrian Zuschmann, Julia Strimitzer

Pride Capital Partners, with offices in Amsterdam, Cologne, and Copenhagen, is a hybrid private equity & debt investor focusing on the software and IT industry. With the acquisition of a minority stake in Vienna-based RUBICON Group, Pride completes its first Austrian investment.

BRANDL TALOS advises Telos Impact on EUR 12 million Series A Financing Round of Kern Tec

• Venture Capital & Start Ups from Roman Rericha, Stephan Strass, Adrian Zuschmann, Daniel Habich

BRANDL TALOS has advised Telos Impact as lead investor on the EUR 12 million Series A financing round of Kern Tec GmbH. The financing round was led by Telos Impact, a leading actor in impact investing, with participation from the PeakBridge Growth II Fund and the European Innovation Council (EIC) Fund.

BRANDL TALOS advises Climentum Capital on €4.5m seed financing round of Fermify

Press release • Corporate Law & Transactions from Roman Rericha, Stephan Strass

BRANDL TALOS has advised European ClimateTech fund Climentum Capital as lead investor on the €4.5 million seed financing round of Vienna-based Fermify GmbH.